About us

Because your research is ours !

Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary  (MDs, PharmDs, vetrinarians and PhDs) who deliver both high quality academic standards and reliable  :

  • Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
  • Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
    Identification of new properties or attributes supporting differentiation of medications within the class or between classes
  • Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities

Our Mission

At Pelvipharm, we are all passionate about our work because we believe we can contribute to life-changing research and improvement of people’s quality of life. We are strongly committed to every project we are entrusted with. Customer Satisfaction and Business Ethics are the pillars of our strategy. Flexibility, Reactivity, Confidentiality and Traceability of study results allow us to best answer our client’s needs and comply with its deadlines. We strive to provide you with our Taylor-made Expertise and Optimized Capabilities to meet your exact requirements.

Letter from the President

Dear Valued Partner,

If we’ve learned anything in the past years, it’s that science matters.

At Pelvipharm, we believe that every disease should be approached with the same sense of urgency. That is exactly why Pelvipharm was founded back in 1999. By offering its unique expertise, we help scientists design complex research studies and carry out more innovative experiments in less time and at a lower cost.
We are constantly launching new models and techniques and contributing to the growing available scientific literature. We believe in an agile approach to drug research and strive to contribute to how science improves people’s lives in the future thanks to the work we do together today!

Delphine BEHR-ROUSSEL, President and the entire Pelvipharm team

Our Platforms

We offer a comprehensive list of in vitro and in vivo models covering a wide range of indications and using various platforms.

Facilities_1_1_1

Each lab is dedicated for either in vivo, ex vivo, biochemical, molecular biology or (immuno)-histological studies on animal or human tissue.

  • In vivo experiments in anaesthetized animals
  • Behavioral experiments in conscious animals and telemetric studies
  • Electrophysiology / stereotaxy / neuroanatomical tracings
  • In vitro / ex vivo experiments (organ bath chambers, incubators)
  • Laboratory Level 2 (High-security) for authorized experiments by ANSM (Agence Nationale de Securité du Médicament)
  • Biochemical and molecular biology analysis (Elisa, Spectrometry, Western blots, RT-PCR)
  • Histology / Histomorphometry / Immunohistochemistry (Cryostat, microscope, confocal microscope)
Facilities_2_1_1

Animal facilities managed by Pelvipharm

In vivo experiments in conscious animals, behavioral or telemetric studies are performed in specific isolated and dedicated rooms within the animal housing facilities.

  • Housing rooms for different species
  • Surgery rooms
  • Treatment rooms
  • Behavioral rooms
  • Cleaning rooms

Our Certifications

  • Our state-of-the-art animal facility is managed by qualified technicians. All experimental studies are fully compliant with Directive 2010/63/EU, follow the principle of the 3R’s (Refine-Reduce-Replace) and have received official authorizations reviewed by our ethics committee and the French Ministry of Higher Education, Research and Innovation (MESRI). Our internal animal well-being training program with emphasis on animal welfare allows steady improvement of our staff’s skills.
  • We have been presiding the French Ethics Committee CEEA-47 since 2011.
  • We are fully accredited to run studies with micro-organisms and toxins (MOT) by the French Agency of Drug Safety (ANSM-Agence de Sécurité du Médicament).

Our Staff

The team is made up of scientists and research technicians who bring years of experience and knowledge into the preclinical research models we perform in our laboratories. Our employees average 9.1 years with the company. Globally, more than 30% of our employees have more than 15 years of service, thereby maintaining a low level of employee turnover and guaranteeing technical stability and robustness. The direct links forged between your lab and ours are the grounds of a fruitful working relationship. Our project management is based on transparency with regular project reporting as often as requested.

Our partners / Clients

  • We have been entrusted with projects from Clients all over the world -
  • Asia : Japan, South Korea, China
  • Australia
  • Europe : France, Germany, Italy, Spain, UK, Russia, Sweden, Switzerland, Finland, Denmark
  • North America : USA and Canada
  • South America : Brazil
  • Middle East : Israel
suisse@2x

We have published with :

  • More than 60 clients have entrusted us with their projects, from small start-ups/virtual companies to big pharmas, among which more than 50% are now repeat clients
logo_ok
UFR Simone Veil - Santé
Université de Versailles St Quentin en Yvelines
2 Avenue de la Source de la Bièvre - 78180 Montigny-Le-Bretonneux FRANCE